Skip to main content

Advertisement

We're creating a new version of this page. See preview

  • Research Article
  • Open Access

HIV and intestinal parasite co-infections among a Chinese population: an immunological profile

  • 1,
  • 2,
  • 1,
  • 2,
  • 1,
  • 2,
  • 1,
  • 3,
  • 4, 5 and
  • 1Email author
Infectious Diseases of Poverty20132:18

https://doi.org/10.1186/2049-9957-2-18

©  Tian et al.; licensee BioMed Central Ltd. 2013

  • Received: 22 April 2013
  • Accepted: 21 August 2013
  • Published:

Abstract

Background

Parasite infections often result in a switch of the human body’s predominant immune reaction from T-helper 1 (Th1)-type to Th2-type. Hence, parasite infections are widely expected to accelerate the progression of human immunodeficiency virus (HIV) infections to acquired immunodeficiency syndrome (AIDS). In the People’s Republic of China, both parasitic diseases and AIDS are epidemic in certain rural areas, and co-infections are relatively common. However, no population-based studies have yet investigated the frequency of HIV and parasite co-infections, and its effects on immune responses. We studied (1) the immune status of an HIV-infected population, and (2) the effect of co-infection of HIV and intestinal parasites on selected parameters of the human immune system.

Methods

A total of 309 HIV-infected individuals were recruited and compared to an age-matched and sex-matched control group of 315 local HIV-negative individuals. Questionnaires were administered to all participants to obtain information on sociodemographic characteristics, sanitation habits, family income, and recent clinical manifestations. Two consecutive stool samples and 10 ml samples of venous blood were also collected from each individual for the diagnosis of parasite infections and quantitative measurements of selected cytokines and CD4+ T-lymphocytes, respectively.

Results

During the study period, 79 HIV-infected individuals were not under highly active antiretroviral therapy (HAART) and were thus included in our analysis; the prevalence of intestinal helminth infections was 6.3% and that of protozoa was 22.8%. The most common protozoan infections were Blastocystis hominis (B. hominis) (13.9%) and Cryptosporidium spp. (10.1%). The prevalence of Cryptosporidium spp. in HIV-infected individuals was significantly higher than that in HIV negative individuals (P < 0.05). Compared to the non-co-infected population, no significant difference was found for any of the measured immunological indicators (P > 0.05). However, the following trends were observed: IFN-γ levels were lower, but the IL-4 level was higher, in the population co-infected with HIV and helminths. In the population co-infected with HIV and B. hominis, the IL-2 level was higher. The population co-infected with HIV and Cryptosporidium spp. had markedly lower CD4+ T-lymphocyte counts.

Conclusion

According to the immunologic profile, co-infection with helminths is disadvantageous to HIV-infected individuals. It was associated with a shift in the Th1/Th2 balance in the same direction as that caused by the virus itself, which might indicate an acceleration of the progress from an HIV infection to AIDS. Co-infection with Cryptosporidium spp. was not associated with a significant change in immune factors but co-infection with Cryptosporidium spp. was associated with a reduced level of CD4 + T-lymphocytes, confirming the opportunistic nature of such infections. Co-infection with B. hominis, on the other hand, was associated with an antagonistic shift in the immunological profile compared to an HIV infection.

Keywords

  • HIV
  • Intestinal parasite
  • Co-infection
  • Immunological profile
  • People’s Republic of China

Multilingual abstracts

Please see Additional file 1 for translations of the abstract into the six official working languages of the United Nations.

Background

HIV/AIDS is a global health problem [1], as are parasite infections [2]. Co-infections of HIV and parasites including intestinal protozoa and helminths are particular concerns as both are rampant in low-income areas where the health status of the population has traditionally been low, even before the advent of HIV [3]. The detrimental health effects of intestinal parasite infections, such as chronic diarrhea, weight loss, and malnutrition might be major causes of death among AIDS patients [4]. HIV undermines the human immune system resulting in an increased chance of infection with certain opportunistic and other parasite species (e.g. Cryptosporidium spp., microsporidia, Giardia intestinalis, and Strongyloides stercoralis) [5–12]. HIV is also suspected to negatively impact the natural evolution of certain parasite infections and lead to more serious clinical symptoms, as well as complicating treatment [13, 14]. On the other hand, the mucosal damage caused by many parasite infections could result in an increased susceptibility to HIV infections [15]. In addition, immunological changes caused by parasite infections may facilitate HIV replication and accelerate disease progression [16–18].

Immunological studies have shown that T-helper 1 (Th1)-type immune responses are associated with viral infections [16] while the immune response of the human body in the face of helminth infections often shifts from Th1-type to Th2-type [19]. Since Th1 cells are necessary to control HIV, parasite infections are suspected to accelerate the progression of HIV infections to AIDS [20, 21]. It is thus of great importance to understand the immune response of individuals co-infected with HIV and parasitic infections in order to predict the course of infection in co-infected individuals. This would allow HIV infections to be managed more effectively, contributing to an improved quality of life for HIV patients.

In the People’s Republic of China (P.R. China), both intestinal parasitic diseases and AIDS are endemic in rural areas [22–26]. Therefore, co-infections of HIV and intestinal parasites are likely, however, the phenomenon has not really been studied in detail. Results from our investigations show that the prevalence of intestinal protozoa is as high as 23.2% among HIV-infected individuals in a typical rural setting [27]. However, no population-based studies on HIV and parasite co-infections and its effects on immune responses have yet been conducted in the country [27]. The objectives of this study were to: (1) reveal the immune status of an HIV-infected population; and (2) evaluate the effects of HIV and intestinal parasite co-infections on selected parameters of the human immune system.

Methods

Study population

The study was conducted in Fuyang in the Anhui Province in P.R. China between June and August 2008. The criteria for participants were: (1) 6–65 years of age, (2) ability to give written informed consent or to obtain assent by legal guardians, and (3) absence of obvious mental illnesses or other diseases affecting investigation procedures.

HIV-infected individuals registered with local and provincial health departments were contacted for inclusion in the study. A control group of HIV-negative individuals residing in the same communities was then identified, matched by age and sex. The control group was recruited from family members of HIV-infected study participants and, if no suitable controls were available, from people in their neighborhood.

Questionnaire and sample collection

Questionnaires were administered to all study participants by health professionals from the local Center for Disease Control and Prevention (CDC). All interviewers had training for routine tasks related to HIV care and prevention. Questions focused on sociodemographic characteristics, sanitation habits, family income, and recent clinical manifestations. One fresh stool samples was collected from each study participant over several days, with a second sample collected whenever possible to maximize the sensitivity of the diagnostic approaches (maximum one sample/day). A 10-ml venous blood sample was also obtained from each study participant.

Laboratory tests

Current HIV – and intestinal parasite infection status, cytokine concentration, and CD4+ T-lymphocyte counts – were determined for all study participants. HIV infections were diagnosed using an enzyme-linked immunosorbent assay (ELISA; Beijing Jinhao Biologic Medicine Company, P.R. China). The critical cutoff value was calculated as the mean optical density (OD) value of the positive controls multiply by 10%. Individuals with an OD value below the critical value were considered HIV negative. ELISA-positive samples were subject to confirmation by Western blot (HIV Blot 2.2 WB; Genelabs Diagnostics, Singapore). Individuals with two positive test results were confirmed as HIV positive. Both tests were conducted in the local CDC station.

The CD4+ T-lymphocyte counts were determined using FACSCalibur flow cytometry (Becton Dickinson, USA). Quantitative ELISA kits (Shanghai Fuzhong Science and Technology Company, P.R. China) were used to measure cytokine concentrations in the serum. Tested cytokines included IL-2, IL-4, IL-10, and IFN-γ. Both CD4+ T-lymphocyte and cytokine measurements were completed by staff of the National Institute of Parasitic Diseases in Shanghai and the Institute of Parasitic Diseases of the Anhui Province.

The Kato-Katz [28] and charcoal culture methods [29] were used to diagnose intestinal helminth infections. The focus was on detecting common soil-transmitted helminths (Ascaris lumbricoides, hookworm, Trichuris trichiura), Clonorchis sinensis, and Strongyloides stercoralis. Eggs of the former four species were identified morphologically by examining three Kato-Katz slides from each stool sample while S. stercoralis larvae were detected by the charcoal culture method. For the diagnosis of protozoa, an in vitro culture method [30] was employed to detect B. hominis while Cryptosporidium spp. was detected by modified acid-fast staining [31]. G. intestinalis and Entamoeba spp. were detected by the Lugol’s iodine method [22]. A positive result in any of the two samples submitted by an individual was sufficient to diagnose an infection.

Statistical analysis

All data were entered twice into a database established using EpiData 3.1. The Student’s t-test, Dunnett t test, variance analysis, and χ2 testing were used for statistical data analysis in SAS9.1, as appropriate.

An optimized immune function model (1) [32] was used to analyze changes in immune response and synergistic effects.
T = IFN ‒ γ IFN ‒ γ + IL ‒ 4
(1)

Here, T is defined as the proportion of cytokines associated with Th1-type cells in the total cytokine pool. IFN-γ is considered as an indicator of Th1 responses and IL-4 as an indicator of Th2 responses.

Ethical considerations

The study protocol was approved by the institutional review board of the National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention in Shanghai. Potential study participants were contacted through the village leaders, and the objectives, procedures, and potential risks were carefully explained. Interested individuals provided written informed consent in person or, in the case of minors, assent was granted by parents or legal guardians before enrolment into the study. All participants were offered professional counseling before and after HIV testing by staff of the local AIDS prevention and treatment agencies where they were enrolled for free treatment and follow-up. Free anthelmintics (albendazole, praziquantel) were offered to all participants found to be infected with helminths through local healthcare institutions. All diagnostic results and other data collected in the frame of the study were strictly confidential.

Results

Participation and demographic information

A total of 624 individuals were enrolled into the study. Among them, 590 individuals (278 males and 312 females; 296 HIV-infected and 294 HIV-negative) provided samples of sufficient quality and quantity to perform all three examinations, i.e. parasite diagnosis in stool, and cytokine and CD4+ T-lymphocyte quantification in blood (see Figure 1). The 217 HIV-infected individuals that were at that time undergoing highly active antiretroviral therapy (HAART) were excluded from analyses focusing on immune functions as the treatment affected their immune response. Therefore, only 79 out of 296 HIV-infected individuals were included in relevant subsequent analyses. The average age of the study participants was 42.5 years – 42.8 years for the HIV-infected group (n = 79) and 41.6 years for the HIV-negative group (n = 294).
Figure 1
Figure 1

Number of study participants at various stages of recruitment.

Parasite infections

Among the 79 HIV-infected individuals who were not on HAART, the overall prevalence of helminth infections was 6.3% (5/79) and that of protozoa infection was 22.8% (18/79). B. hominis and Cryptosporidium spp. were the most common species: their prevalence was 13.9% (11/79) and 10.1% (8/79), respectively. Three individuals were infected with both B. hominis and Cryptosporidium spp.

Among the 294 HIV-negative individuals, 5.4% (16/294) were infected with helminthes and 24.8% (73/294) with protozoa. Both prevalences were not significantly different from the recorded value among the HIV-infected population. Five individuals were infected with both helminths and protozoa. The prevalence of B. hominis in the HIV-negative population was markedly higher (21.8%) than that in the HIV-infected population (13.9%), whereas that of Cryptosporidium spp. was significantly lower in the HIV-negative population (3.1%) compared to the HIV-infected population (10.1%) (P = 0.0134). The parasite infections in the HIV-positive and -negative populations are shown in Table 1.
Table 1

Prevalence of parasitic infections among HIV-infected and HIV-negative study participants

Variate

HIV infected (n = 79)% (No. positive)

HIV negative (n = 294)% (No. positive)

P value

Ascaris lumbricoides

0

0.68 (2)

1.0000*

Hookworm

6.33 (5)

4.42 (13)

0.5548*

Trichuris trichiura

0

0.34 (1)

1.0000*

Clonorchis sinensis

0

0.68 (2)

1.0000*

Any helminthes

6.33 (5)

5.44 (16)

0.7840*

Giardia intestinalis

1.26 (1)

0.34 (1)

0.3828*

Blastocystis hominis

13.92 (11)

21.77 (64)

0.1225

Entamoebae spp.

3.80 (3)

0.68 (2)

0.2914*

Cryptosporidium spp.

10.13( 8)

3.06 (9)

0.0134*

Any protozoa

22.78 (18)

24.83 (73)

0.7071

*tested by the Fisher exact test, others tested by the chi-square test.

Immune factor profile

The major differences between immune factors in the HIV-positive and -negative populations are shown in Table 2. Compared to the HIV-negative group (294 individuals), the average count of CD4+ T-lymphocytes in the HIV-positive group (79 individuals) was significantly lower (P < 0.0001). The level of IL-2 and IL-4 was higher in the HIV-infected group compared to the HIV-negative control group. However, IFN-γ and IL-10 levels were not significantly different in the two groups. As a result, the T value of the HIV-positive group (0.35) is significantly lower than that of the in HIV-negative group (0.45). The pattern remained the same if participants with parasitic infections were excluded from the analysis (second column in Tables 3 and 4).
Table 2

Levels of selected immunological indicators in HIV-infected and HIV-negative study participants

 

HIV-infected (n = 79) x ¯ ± s

HIV negative (n = 294) x ¯ ± s

P value

CD4+

518.12 ± 253.56

829.89 ± 261.77

<.0001

IL-2

87.92 ±57.13

57.19 ± 41.29

<.0001*

IL-4

25.06 ±17.15

14.72 ± 8.52

<.0001*

IL-10

20.79 ±25.70

25.59 ± 47.72

0.2330*

IFN-γ

12.58 ±7.69

12.37 ± 7.65

0.8236

T**

0.35 ±0.17

0.45 ± 0.19

<.0001

*variance was uneven; using the Satterthwaite test.

**T = IFN-γ/(IFN-γ + IL-4).

Table 3

Levels of selected immunological indicators in HIV-negative individuals, stratified by parasitic infection status

 

Without parasite infection

Only helminth infections

Only B. hominis infection

Only Cryptosporidium spp. infection

Both helminth and protozoan infections

P-Value**

 

(n = 210) x ¯ ± s

(n = 11) x ¯ ± s

(n = 56) x ¯ ± s

(n = 9) x ¯ ± s

(n = 5) x ¯ ± s

 

CD4+

842.2 ± 270.5

802.5 ± 219.8

794.6 ± 249.6

739.8 ± 175.9

937.6 ± 251.9

0.4796

IL-2

56.4 ± 41.4

69.8 ± 49.0

55.6 ± 40.3

64.2 ± 45.2

58.9 ± 46.7

0.8432

IL-4

14.8 ± 9.0

15.5 ± 6.3

14.3 ± 6.6

15.1 ± 12.0

13.0 ± 6.6

0.9801

IL-10

25.4 ± 51.0

22.1 ± 25.1

28.5 ± 43.0

27.6 ± 38.6

8.3 ± 5.3

0.9212

IFN-γ

12.3 ± 7.2

13.8 ± 12.5

12.0 ± 7.0

11.2 ± 5.5

10.1 ± 2.9

0.8762

T*

0.5 ± 0.2

0.4 ± 0.2

0.4 ± 0.2

0.5 ± 0.3

0.5 ± 0.2

0.9135

* T = IFN-γ/(IFN-γ + IL-4).

**Dunnett t test was applied in paired comparison among groups and group 1 was the control group; P > 0.05.

Table 4

Levels of selected immunological indicators in HIV-infected individuals, stratified by parasitic infection status

 

Without parasitic infection

Only helminth infections

Only B. hominis infection

Only Cryptosporidium. spp. infection

P-Value**

 

(n = 56) x ¯ ± s

(n = 5) x ¯ ± s

(n = 8) x ¯ ± s

(n = 7) x ¯ ± s

 

CD4+

520.3 ± 238.7

420.8 ± 262.1

668.0 ± 401.8

411.0 ± 141.5

0.2006

IL-2

82.6 ± 53.8

70.6 ± 65.8

121.3 ± 68.4

100.8 ± 69.4

0.2725

IL-4

23.6 ± 17.6

23.8 ± 22.1

28.6 ± 15.5

27.1 ± 14.0

0.8599

IL-10

22.2 ± 29.8

18.3 ± 7.0

19.0 ± 9.4

18.5 ± 12.8

0.9655

IFN-γ

12.5 ± 6.7

7.5 ± 5.7

12.4 ± 4.7

16.2 ± 11.4

0.3078

T*

0.4 ± 0.2

0.3 ± 0.2

0.3 ± 0.2

0.4 ± 0.2

0.7041

* T = IFN-γ/(IFN-γ + IL-4).

**Dunnett t test was applied in paired comparison among groups and group 1 was the control group; P > 0.05.

Immune factors and parasite infection status

In both HIV-infected individuals and those who were HIV negative, no significant difference was found for any of the measured immunological indicators in people with different parasite infections (see Tables 3 and 4). However, a trend towards lower IFN-γlevels in individuals co-infected with HIV and helminths was observed, albeit with marked variation between individual values. In contrast, the level was elevated in individuals co-infected with HIV and Cryptosporidium spp. The IL-4 level in HIV-infected individuals was generally higher than that in HIV-negative controls regardless of parasite infection status. While the IL-4 level was stable across the HIV-negative population, it appeared to fluctuate in the HIV-infected population according to their infection status with different parasite species. For example, the level was higher when co-infection of HIV and B. hominis was present. As a result, the T value was lower in HIV-positive individuals than in the HIV-negative control group, indicating that the immune responses in HIV-infected individuals co-infected with worms was predominantly of Th2 type.

The IL-2 level in the HIV-infected population was generally higher than in the HIV-negative control group. However, no significant difference between these two groups was observed in the helminth-infected subpopulation. Of note, in the HIV-infected group, the IL-2 level was higher in the case of co-infection with Cryptosporidium spp. or B. hominis. However, in the HIV-negative control group, the IL-2 level was not markedly different if an infection with Cryptosporidium spp. or B. hominis was present.

IL-10 levels were slightly lower in the HIV-infected study participants compared to the HIV-negative control group. The difference considerably increased when B. hominis and Cryptosporidium spp. were involved.

CD4+ T-lymphocyte levels were significantly lower in the HIV-positive individuals (P < 0.01) compared to their HIV-negative counterparts. Among the individuals co-infected with HIV and helminths or Cryptosporidium spp., CD4+ T-lymphocyte levels were even lower. In contrast, co-infection of HIV and B. hominis was associated with higher CD4+ T lymphocyte levels.

Discussion and conclusions

It is now widely accepted that by undermining the human immune response, HIV infections facilitate the establishment of opportunistic parasite infections such as Pneumocystis spp., microsporidia, and Cryptosporidium spp. [33–35]. Indeed, our findings show that the prevalence of Cryptosporidium spp. in the HIV-infected population was 10.1%, significantly higher than that of 3.1% among HIV-negative group. The immune profile of HIV-infected individuals was markedly different from that of their HIV-negative peers. However, no significant change in immune system indicators was observed when individuals with HIV infections but no parasite co-infection were compared to those with such co-infections. Cryptosporidium spp. infections in HIV-infected individuals often cause severe diarrhea and malnutrition, and can even lead to death among AIDS patients [36].

B. hominis is one of the most common human intestinal parasite infections. B. hominis is usually considered a commensal (non-pathogenic) protozoa inhabiting the human intestine, although previous studies have suggested that it has certain pathogenicity [37–39]. Interestingly, the prevalence of B. hominis among HIV-infected individuals was actually lower than that among the controls in our study.

The appropriate immune reaction against helminth infections is believed to be provided by Th2 cells which inhibit the development of Th1 cells, and hence prevent them and macrophages from mounting massive immune reactions against the comparatively very large parasites – a reaction which would potentially be harmful for the human body [40, 41]. The progression from HIV infection to AIDS is characterized by a decrease of Th1-type immune responses whereas Th2-type responses increase [42–44]. In our study, 6.3% of the HIV-infected participants were co-infected with intestinal helminthes, and the level of IFN-γ and IL-10 was lower among these co-infected individuals while the level of IL-4 was higher. The Th2-type immune response was elevated and the T value (T = Th1 / (Th1 + Th2) decreased. Thus, the co-infection of HIV and helminths acted synergistically in shifting the Th1/Th2 balance which might indicate an acceleration of the progress from HIV infection to AIDS. It was further observed that in individuals with HIV and B. hominis co-infection, CD4 levels were slightly lower compared to individuals without a B. hominis infection, while IFN-γ and other cytokine levels did not change significantly and IL-2 levels were higher. IL-2 is indispensable for cell-mediated immune responses against parasitic infections and humoral immunity. Therefore, the presence of B. hominis may even be favorable for HIV-positive individuals as IL-2 induces T cells to secrete IFN-γ, and the latter is an important factor in anti-viral immune reactions. The promotion of human B cell proliferation should inhibit IL-4. However, in our study IL-4 levels were found to be slightly higher. To sufficiently determine the reasons, further studies need to be conducted. The IL-10 level was slightly lower if co-infection of HIV and B. hominis was present. IL-10 can inhibit Th1-stimulating cytokine secretion. Together, these findings indicate, once again, a need to further study the pathogenicity of B. hominis in order to better determine its status as a member of the intestinal flora [45–47].

In conclusion, co-infection with helminths was associated with potentially detrimental changes of the immunologic profile of HIV-infected individuals. Helminth infections appeared to act synergistically with HIV in shifting the Th1/Th2 balance, a shift which has traditionally be seen as indicative of an acceleration of the progress from HIV infection to AIDS. On the other hand, co-infection with protozoa was imperceptible in the immune response profile: co-infection with Cryptosporidium spp. was not associated with any significant change in studied immune factors while co-infection with B. hominis was associated with favorable shifts in the immune profile.

Declarations

Acknowledgements

This work was supported by the National S & T Major Program (Grant No. 2012ZX10004-220 and 2008ZX10004-011), the National Key Technology R&D Program (No.2008BAI56B03, and the Health Research in the Public Interest (Grant No. 201202019)).

Authors’ Affiliations

(1)
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (China CDC); WHO Collaborating Centre for Malaria, Schistosomiasis and Filariasis; Key Laboratory of Parasite and Vector Biology, Ministry of Health, Shanghai, 200025, People’s Republic of China
(2)
Anhui Institute of Parasitic Disease Control, Hefei, 241000, People’s Republic of China
(3)
University of Oklahoma, Midwest, 73110 OK, USA
(4)
Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, 4051, Switzerland
(5)
University of Basel, Basel, 4051, Switzerland

References

  1. Salim SAK, Quarraisha AK, Eleanor G, Cheryl B: Global epidemiology of HIV-AIDS. Infect Dis Clin North Am. 2007, 21: 1-17. 10.1016/j.idc.2007.01.010.View ArticleGoogle Scholar
  2. Brooker S: Estimating the global distribution and disease burden of intestinal nematode infections: adding up the numbers–a review. Int J Parasitol. 2010, 40: 1137-1144. 10.1016/j.ijpara.2010.04.004.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Tzipori S, Widmer G: A hundred-year retrospective on cryptosporidiosis. Trends Parasiol. 2008, 24: 184-189. 10.1016/j.pt.2008.01.002.View ArticleGoogle Scholar
  4. Feitosa G, Bandeira AC, Sampaio DP, Badaró R, Brites C: High prevalence of giardiasis and strongyloidiasis among HIV infected patients in Bahia, Brazil. Brazil J Infect Dis. 2001, 5: 339-344.Google Scholar
  5. Lindo JF: Intestinal parasitic infections in human immunodeficiency virus (HIV)-positive and HIV-negative individuals in San Pedro Sula, Honduras. Am J Trop Med Hyg. 1998, 58: 431-435.PubMedGoogle Scholar
  6. Ramakrishnan K, Shenbagarathai R, Uma A, Kavitha K, Rajendran R, Thirumalaikolundusubramanian P: Prevalence of intestinal parasitic infestation in HIV/AIDS patients with diarrhea in Madurai City, South India. Jpn J Infect Dis. 2007, 60: 209-210.PubMedGoogle Scholar
  7. Tian LG, Zhou XN: Intestinal parasitic infections neglected in the HIV/AIDS patients. Chin J Parasitol Parasit Dis. 2008, 26: 376-381. (in Chinese)Google Scholar
  8. Karp CL, Auwaerter PG: Coinfection with HIV and tropical infectious diseases I. Protozoal pathogens. Clin Infect Dis. 2007, 45: 1208-1213. 10.1086/522181.View ArticlePubMedGoogle Scholar
  9. Karp CL, Auwaerter PG: Coinfection with HIV and tropical infectious diseases. II. Helminthic, fungal, bacterial, and viral pathogens. Clin Infect Dis. 2007, 45: 1214-1220. 10.1086/522180.View ArticlePubMedGoogle Scholar
  10. Mendez OC, Szmulewicz G, Menghi C, Torres S, Gonzalez G, Gatta C: Comparison of intestinal parasite infestation indexes among HIV positive and negative populations. Medicina (B Aires). 1994, 54: 307-310.Google Scholar
  11. Noureldin MS, Shaltout AA, El Hamshary EM, Ali ME: Opportunistic intestinal protozoal infections in immunocompromised children. J Egy Soc Parasitol. 1999, 29: 951-961.Google Scholar
  12. Harms G, Feldmeier H: HIV infection and tropical parasitic diseases - deleterious interactions in both directions?. Trop Med Int Health. 2002, 7: 479-488. 10.1046/j.1365-3156.2002.00893.x.View ArticlePubMedGoogle Scholar
  13. Corbett EL, Steketee RW, ter Kuile FO, Latif AS, Kamali A, Hayes RJ: HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet. 2002, 359: 2177-2187. 10.1016/S0140-6736(02)09095-5.View ArticlePubMedGoogle Scholar
  14. Humphrey DM, Fred N, Shona W, Safari MK, Domenica M, Rebecca W, Jorg H, David WD: Epidemiology and interactions of human immunodeficiency virus – 1 and schistosoma mansoni in sub-Saharan Africa. Inf Dis Poverty. 2013, 2: 2-10.1186/2049-9957-2-2.View ArticleGoogle Scholar
  15. Gopinath R, Ostrowski M, Justement SJ, Fauci AS, Nutman TB: Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro. J Infect Dis. 2000, 182: 1804-1808. 10.1086/317623.View ArticlePubMedGoogle Scholar
  16. Clerici M, Shearer GM:A TH1 TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993, 14: 107-111. 10.1016/0167-5699(93)90208-3.View ArticlePubMedGoogle Scholar
  17. Xiao L, Lal RB, Lal AA: Effect of immune activation induced by cryptosporidium parvum whole antigen on in vitro human immunodeficiency virus type 1 infection. J Infect Dis. 1999, 180: 559-563. 10.1086/314885.View ArticlePubMedGoogle Scholar
  18. Xiao L, Owen SM, Rudolph DL, Lal RB, Lal AA: Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha. J Infect Dis. 1998, 177: 437-445. 10.1086/514212.View ArticlePubMedGoogle Scholar
  19. Sergio R: The Th1/Th2 paradigm. Immunol Today. 1997, 18: 263-266.Google Scholar
  20. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A, Coffman RL, Shearer GM: Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest. 1994, 93: 768-775. 10.1172/JCI117031.PubMed CentralView ArticlePubMedGoogle Scholar
  21. Maggi E, Mazzetti M, Ravina A, Annunziato F, De Carli M, Piccinni MP, Manetti R, Carbonari M, Pesce AM, Del Prete G: Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science. 1994, 265: 244-248. 10.1126/science.8023142.View ArticlePubMedGoogle Scholar
  22. Xu LQ, Chen YD, Sun FH: A national survey on current status of the important parasitic diseases in human population. Chin J Parasitol Parasit Dis. 2005, 23: 332-340. (in Chinese)Google Scholar
  23. Qu FY: Historical review on the development of medical parasitology in China during the years of 1871–2006. Chin J Parasitol Parasit Dis. 2007, 25: 259-273. (in Chinese)Google Scholar
  24. Xu LQ, Xu SZ: Characteristics and recent trends in endemicity of human parasitic diseases in China. Chin J Parasitol Parasit Dis. 1995, 13: 214-217. (in Chinese)Google Scholar
  25. Shao Y: AIDS epidemic at age 25 and control efforts in China. Retrovirology. 2006, 3: 87-10.1186/1742-4690-3-87.PubMed CentralView ArticlePubMedGoogle Scholar
  26. Tian LG, Steinmann P, Chen JX, Chen SH, Zhou XN: HIV/AIDS, parasites and co-infections: publication patterns in China. Parasit Vectors. 2009, 2: 31-10.1186/1756-3305-2-31.PubMed CentralView ArticlePubMedGoogle Scholar
  27. Tian LG, Chen JX, Wang TP, Cheng GJ, Steinmann P, Wang FF, Cai YC, Yin XM, Guo J, Zhou L, Zhou XN: Co-infection of HIV and intestinal parasites in rural area of China. Parasit Vectors. 2012, 5: 36-10.1186/1756-3305-5-36.PubMed CentralView ArticlePubMedGoogle Scholar
  28. Katz N, Chaves A, Pellegrino J: A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1972, 14: 397-400.PubMedGoogle Scholar
  29. Koga K, Kasuya S, Khamboonruang C, Sukhavat K, Ieda M: A modified agar plate method for detection of Strongyloides stercoralis. Am J Trop Med Hyg. 1991, 45: 518-521.PubMedGoogle Scholar
  30. Taamasri P, Leelayoova S, Rangsin R, Naaglor T, Ketupanya A: Prevalence of Blastocystis hominis carriage in Thai army personnel based in Chonburi, Thailand. Mil Med. 2002, 167: 643-646.PubMedGoogle Scholar
  31. Arikan S, Ergüven S, Aky nY, Günalp A: Cryptosporidiosis in immunocompromised patients in a Turkish university hospital. Acta Microbiol Immunol Hung. 1999, 46: 33-40. 10.1556/AMicr.46.1999.1.4.View ArticlePubMedGoogle Scholar
  32. Graham AL: Use of an optimality model to solve the immunological puzzle of concomitant infection. Parasitol. 2007, 122: 61-64.View ArticleGoogle Scholar
  33. Fincham JE, Markus MB, Adams VJ: Could control of soil-transmitted helminthic infection influence the HIV/AIDS pandemic. Acta Trop. 2003, 86: 315-333. 10.1016/S0001-706X(03)00063-9.View ArticlePubMedGoogle Scholar
  34. Pinlaor S, Mootsikapun P, Pinlaor P, Pipitgool V, Tuangnadee R: Detection of opportunistic and non-opportunistic intestinal parasites and liver flukes in HIV-positive and HIV-negative subjects. Southeast Asian J Trop Med Pub Health. 2005, 36: 841-845.Google Scholar
  35. Deodhar L, Maniar JK, Saple DG: Cyclospora infection in acquired immunodeficiency syndrome. J Assoc Physicians India. 2000, 48: 404-406.PubMedGoogle Scholar
  36. Mohandas K, Sehgal R, Sud A, Malla N: Prevalence of intestinal parasitic pathogens in HIV-seropositive individuals in Northern India. Jpn J Infect Dis. 2002, 55: 83-84.PubMedGoogle Scholar
  37. Babb RR, Wagener S: Blastocystis hominis - a potential intestinal pathogen. West J Med. 1989, 151: 518-519.PubMed CentralPubMedGoogle Scholar
  38. Jelinek T, Peyerl G, L scher T, Von Sonnenburg F, Nothdurft HD: The role of Blastocystis hominis as a possible intestinal pathogen in travellers. J Infect. 1997, 35: 63-66.View ArticlePubMedGoogle Scholar
  39. Zierdt CH: Blastocystis hominis - past and future. Clin Microbiol Rev. 1991, 4: 61-79.PubMed CentralPubMedGoogle Scholar
  40. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, Ho HN, Nishanian PG, Berzofsky JA, Shearer GM: Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis. 1992, 165: 1012-1019. 10.1093/infdis/165.6.1012.View ArticlePubMedGoogle Scholar
  41. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, Shearer GM: Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science. 1993, 262: 1721-1724. 10.1126/science.7903123.View ArticlePubMedGoogle Scholar
  42. Barcellini W, Rizzardi GP, Borgh MO, Fain C, Lazzarin A, Meroni PL: TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV infected patients. Aids. 1994, 8: 757-762. 10.1097/00002030-199406000-00006.View ArticlePubMedGoogle Scholar
  43. Maggi E, Giudizi MG, Biagiotti R, Annunziato F, Manetti R, Piccinni MP, Parronchi P, Sampognaro S, Giannarini L, Zuccati G: Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med. 1994, 180: 489-495. 10.1084/jem.180.2.489.View ArticlePubMedGoogle Scholar
  44. Graziosi C, Pantaleo G, Gantt KR, Fortin JP, Demarest JF, Cohen OJ, Sekaly RP, Fauci AS: Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV infected individuals. Science. 1994, 265: 248-252. 10.1126/science.8023143.View ArticlePubMedGoogle Scholar
  45. Ashford RW, Atkinson EA: Epidemiology of Blastocystis hominis infection in Papua New Guinea: age-prevalence and association with other parasites. Ann Trop Med Parasitol. 1992, 86: 129-136.PubMedGoogle Scholar
  46. Chen T, Chan C, Chen H, Fung CP, Lin C, Chan W, Liu CYI: Clinical characteristics and endoscopic findings associated with Blastocystis hominis in healthy adults. Am J Trop Med Hyg. 2003, 69: 213-216.PubMedGoogle Scholar
  47. Zuckerman MJ, Watts MT, Ho HOI, Meriano FV: Blastocystis hominis infection and intestinal injury. Am J Med Sci. 1994, 308: 96-101. 10.1097/00000441-199408000-00006.View ArticlePubMedGoogle Scholar

Copyright

© Tian et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement

Infectious Diseases of Poverty

ISSN: 2049-9957

Contact us